ICCS 2014: Cutting-edge oncology innovations
On June 22nd, one day prior to the BIO International Convention in San Diego, the International Cancer Cluster Showcase 2014 kicks off. The showcase is an opportunity to head-start the partnering at BIO 2014 and get the latest on what is going on in the cancer clusters of Oslo, Massachusetts, Quebec, Chicago, Toulouse, and the […]
“Helsemyggordningen” proposed for the Norwegian Parliament
The liberal party Venstre have proposed the implementation of the “Helsemyggordningen,” a financial mechanism for stimulation of health innovation, for the Norwegian Parliament. The proposal have been designated to the The Standing Committee on Finance and Economic Affairs in the Parliament. “Helsemyggordningen” was raised for the Norwegian Parliament on March 19th as a so-called Document 8-proposal. […]
The Radium Hospital Foundation support the R&D Network Meetings 2014
The Radium Hospital Foundation (Radiumhospitalets Legater) will support the Oslo Cancer Clusters R&D Network Meetings 2014, and collaborate closely with the cluster on developing these meetings. Oslo Cancer Clusters R&D Network Meetings are the backbone of the clusters strategic goal to stimulate collaborations and partnership by further develop strong national and international networks. Important for […]
Nansen Prize to Professor Kirsten Sandvig
The Fridtjof Nansen prize for excellent research in science and medicine 2014 is awarded to Centre for Cancer Biomedicine’s Kirsten Sandvig for her groundbreaking work within biochemistry and cell biology. Oslo Cancer Cluster congratulates Professor Kirsten Sandvig with the Fridtjof Nansen prize for excellent research in science and medicine (Fridtjof Nansens belønning for fremragende forskning […]
Presentations from Cancer Crosslinks 2014
Cancer Crosslinks 2014, January 23, was the 6th edition of this annual oncology conference bringing together hematologists, oncologists and the industry in Norway. This years conference was developed and hosted in collaboration with partners BMS, Amgen and the Institute for Cancer Research, Oslo University Hospital. The feedback from the more than 220 participants was as […]
Bergen Bio Raises MNOK 75
BerGenBio AS, an oncology biopharmaceutical company, announces that it has raised NOK75 million (c.$12.5 million) from a syndicate of new and existing investors through a private placement. This follows a $6.0 million round in May 2013. Proceeds from the financing will be used to support the development of the Company’s innovative portfolio of innovative cancer […]
